OFF-THE-SHELF CAR T CELL IMMUNOTHERAPY FOR GLIOBLASTOMA

被引：0
|
作者：
Martins, P. [1 ]
D'Souza, R. [1 ]
Smith, C. [1 ]
Day, B. [1 ]
Khanna, R. [1 ]
机构：
[1] QIMR Berghofer Med Res Inst, Herston, Qld, Australia
来源：
CYTOTHERAPY | 2023年 / 25卷 / 06期
关键词：
Glioblastoma; CAR T cells; Ephrin receptor;
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
1055
引用
收藏
页码：S238 / S238
页数：1
相关论文
共 50 条
  • [21] Allogeneic "Off-the-Shelf" CAR T cells: Challenges and advances
    Chen, Sophia
    van den Brink, Marcel R. M.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2024, 37 (03)
  • [22] Minimally modified off-the-shelf allogeneic CAR T cells
    Loos, Pauline
    Evgin, Laura
    MOLECULAR THERAPY ONCOLOGY, 2024, 32 (03):
  • [23] Improvement of "off-the-shelf'' allogeneic CAR-T cells
    Pavlovic, K.
    Carmona, M. D.
    Maldonado, N.
    Tristan, M.
    Cortijo, M.
    Nogueras, S.
    Jimenez, R.
    Martin, F.
    Herrera, I. C.
    Benabdellah, K.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A87 - A87
  • [24] Cashing in with off-the-shelf CAR Ts
    Asher Mullard
    Nature Reviews Drug Discovery, 2018, 17 : 307 - 307
  • [25] Off-the-shelf T-cell therapy
    Cooper, Laurence J. N.
    BLOOD, 2010, 116 (23) : 4741 - 4743
  • [26] Off-the-shelf ipsc derived car-nk immunotherapy for solid tumors
    Boyd, N. R.
    Tiedemann, M.
    Cartledge, K.
    Cao, M.
    Evtimov, V.
    Shu, R.
    Nguyen, T.
    Nguyen, N.
    Nisbet, I.
    Boyd, R.
    Trounson, A.
    CYTOTHERAPY, 2020, 22 (05) : S199 - S199
  • [27] Targeted 'Off-the-Shelf' tumor immunotherapy using allogeneic T-Cell precursors
    Zakrzewski, Johannes L.
    Suh, David
    Smith, Odette M.
    King, Christopher
    Goldberg, Gabrielle L.
    Jenq, Robert
    Holland, Amanda M.
    Grubin, Jeremy
    Lu, Sydney X.
    Cabrera-Perez, Javier
    Rizzuto, Gabrielle
    Sant'Angelo, Derek B.
    van den Brink, Marcel R. M.
    Markley, John C.
    Riviere, Isabelle
    Sadelain, Michel
    Zuniga-Pflucker, Juan Carlos
    BLOOD, 2007, 110 (11) : 178A - 178A
  • [28] OFF-THE-SHELF TUMOR IMMUNOTHERAPY WITH GENETICALLY ENHANCED ALLOGENEIC T-CELL PRECURSORS
    Zakrzewski, J. L.
    Suh, D.
    Markley, J. C.
    Smith, O. M.
    King, C.
    Goldberg, G.
    Jenq, R.
    Holland, A. M.
    Grubin, J.
    Cabrera-Perez, J.
    Lu, S. X.
    Rizzuto, G.
    Sant'Angelo, D. B.
    Riviere, I
    Sadelain, M.
    Zuniga-Pflucker, J. C.
    van den Brink, M. R. M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 126 - 126
  • [29] Optimal, Off-the-Shelf, CAR-iNKT Cell Platform-Based Immunotherapy for Multiple Myeloma
    Ponnusamy, Kanagaraju
    Randzavola, Lyra
    Ren, Hongwei
    Karaxhuku, Klesti
    Lye, Bryan
    Leonardos, Dimitrios
    Nadafi, Reza
    Sarkar, Irene
    Leontari, Ilia
    Sabrin, Farah
    Zaidi, Mehmood
    Bua, Marco
    Atta, Maria
    Katsarou, Alexia
    Roberts, Irene
    Chaidos, Aristeidis
    Karadimitris, Anastasios
    BLOOD, 2023, 142
  • [30] An Off-the-Shelf™ Fratricide-Resistant CAR-T for the Treatment of T Cell Hematologic Malignancies
    Cooper, Matt L.
    Choi, Jaebok
    Staser, Karl W.
    Ritchey, Julie
    Niswonger, Jessica
    Eckardt, Kayla
    Rettig, Michael P.
    Bing, Wang
    Eissenberg, Linda G.
    Ghobadi, Armin
    Gehrs, Leah
    Prior, Julie
    Achilefu, Samuel
    Miller, Christopher A.
    Fronick, Catrina
    O'Neal, Julie
    Gao, Feng
    Weinstock, David M.
    Gutierrez, Alejandro
    DiPersio, Robert S. Fultonand John F.
    BLOOD, 2017, 130
12345